Back to Stocks
Rank #1468PMVP
PMV Pharmaceuticals, Inc.
$1.06
-0.93% (Daily)
Market Cap
$56.40M
Revenue
$N/A
Rank by MCap
#1468
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. David H. Mack Ph.D.
Headquarters
Princeton, NJ
Employees
47
About PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharm...
PMV Pharmaceuticals, Inc. Price Chart
Loading chart…